MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Rigel Pharmaceuticals Company Profile (NASDAQ:RIGL)

Consensus Ratings for Rigel Pharmaceuticals (NASDAQ:RIGL) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.67 (231.89% upside)

Analysts' Ratings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Show:
DateFirmActionRatingPrice TargetActions
6/13/2016Piper JaffrayInitiated CoverageOverweight$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Jefferies GroupReiterated RatingBuy$10.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Credit SuisseUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Wells FargoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q116($0.19)($0.19)$4.00 million$5.03 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.14)($0.14)$8.90 million$8.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.17)($0.08)$5.00 million$12.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.22)($0.16)$2.67 million$5.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q414($0.18)($0.21)$16.00 million$2.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q4($0.27)($0.25)$2.50 million$8.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.27)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214($0.25)($0.29)$1.05 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.25)($0.25)$0.43 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q4 13($0.25)($0.19)$5.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.29)($0.27)$260.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013($0.30)($0.26)$0.53 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.30)($0.29)$1.73 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2013Q4 2012($0.32)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312($0.38)($0.36)$0.84 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.34)($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.33)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012($0.28)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011($0.28)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.36)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.36)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Rigel Pharmaceuticals (NASDAQ:RIGL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161$0.41$0.41$0.41
(Data provided by Zacks Investment Research)
Dividend History for Rigel Pharmaceuticals (NASDAQ:RIGL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/1/2015Donald G PayanEVPSell10,000$3.75$37,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Dolly VanceEVPSell1,000$2.22$2,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Donald G PayanEVPSell20,000$2.56$51,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2013Bvf Partners P/Ilmajor shareholderSell484,622$2.64$1,279,402.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Bvf Partners L P/IlMajor ShareholderBuy32,700$3.47$113,469.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2012Dolly VanceEVPSell4,151$10.43$43,294.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateHeadline
06/25/16 05:34 PMStrong Sell Calls Recommendations For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire
06/25/16 09:51 AMRigel Pharmaceuticals Inc. (RIGL) Jumps 5.56% on June 23 - Equities.com
06/24/16 08:44 AMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Increased By 1.39% - Press Telegraph
06/23/16 08:46 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 20 - Equities.com
06/22/16 10:52 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 20
06/18/16 10:16 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 16 - Equities.com
06/02/16 06:35 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 ...Rigel to Present at Jefferies 2016 Healthcare ConferenceSatellite PR News (press release)all 2 news articles »
06/01/16 09:02 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 30 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 30Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on May. 30, as the stock lost 1.2% to a closing price of $2.46. The stock saw 634,469 shares trade hands over the course of the day on 1,704 trades. Given that the stock's average ...and more »
05/31/16 10:32 AMStrong Sell Calls Count For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire - Strong Sell Calls Count For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0Investor NewswireRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has a total of 2 Strong Buy calls and 0 Strong Sell advises as of 2016-05-30. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is ...and more »
05/31/16 10:32 AMWhat's Ahead for Rigel Pharma (RIGL): A Look Back at Recent Q&A - Equities.com - Equities.comWhat's Ahead for Rigel Pharma (RIGL): A Look Back at Recent Q&AEquities.comI was reading the transcript from the March 2016 Earnings call (see below)..and thought it would be a good time to reach out and get some feedback from Raul Rodriguez, Rigel Pharmaceuticals - CEO as to where they are to date. I like the company who ...
05/25/16 12:05 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Closes At $2.49 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Closes At $2.49Investor NewswireYesterday, the stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) closed at $2.49 after opening at $2.49 and registering high of $2.57 and low of $2.49. The last price is $-1.21 off 1-year high of $3.78 and $0.69 away from low of $1.88 during same period.
05/21/16 11:56 AMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Decreased By 2.09% - Wall Street Hints and News - Rigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Decreased By 2.09%Wall Street Hints and NewsThe short interest to Rigel Pharmaceuticals Incorporated's float is 2.53%. The stock increased 3.32% or $0.08 on May 20, hitting $2.49. About 169,569 shares traded hands. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has declined 16.44% since October 15, ...
05/19/16 06:54 PMETF’s with exposure to Rigel Pharmaceuticals, Inc. : May 19, 2016 -
05/19/16 11:57 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 17 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 17Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on May. 17, as the stock lost 0.83% to a closing price of $2.39. The stock saw 876,390 shares trade hands over the course of the day on 2,966 trades. Given that the stock's average ...Snapshot of Recent Traded Stocks: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) , Radius Health, Inc. (NASDAQ:RDUS)Street Updatesall 2 news articles »
05/18/16 12:41 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hovering Around $2.30 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hovering Around $2.30Investor NewswireOn performing technical analysis of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock, it is noted that the stock is $-0.17 points away -6.65% from its fifty-day MA of $2.50. It is $-0.38 or -13.95% away $2.71, the 200-day MA (Moving Average) of stock ...Next Weeks Broker Price Targets For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Share Trading NewsRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 2.09% of Their ShortsWall Street Hints and NewsJefferies Holds To Rating And Lowers Price Target On Rigel Pharmaceuticals, Inc. (RIGL)Finance Dailyall 6 news articles »
05/17/16 02:54 PMRigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 12:56 PMNext Weeks Broker Price Targets For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Share Trading News - Next Weeks Broker Price Targets For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Share Trading NewsRigel Pharmaceuticals, Inc. has a 50 day moving average of 2.49 and a 200 day moving average of 2.71. The stock's market capitalization is 222.07M, it has a 52-week low of 1.88 and a 52-week high of 4.07. The share price of the company (NASDAQ:RIGL) ...Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hovering Around $2.30Investor NewswireRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 2.09% of Their ShortsWall Street Hints and NewsJefferies Holds To Rating And Lowers Price Target On Rigel Pharmaceuticals, Inc. (RIGL)Finance Dailyall 6 news articles »
05/12/16 03:22 PMRIGEL PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/10/16 12:04 PMRIGEL PHARMACEUTICALS INC Financials -
05/10/16 06:20 AMRigel Pharmaceuticals Inc. (RIGL) Jumps 6.06% on May 09 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) Jumps 6.06% on May 09Equities.comRigel Pharmaceuticals Inc. (RIGL) was among the biggest gainers on the Russell 2000 for Monday May 09 as the stock popped 6.06% to $2.45, representing a gain of $0.14 per share. Some 377,708 shares traded hands on 1,450 trades, compared with an ...and more »
05/09/16 06:14 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Broker Price Targets For The Coming Week - Share Trading News - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 ...Rigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 4.53% of Their ShortsFranklin Independentall 2 news articles »
05/05/16 06:41 AMRigel to Present at Upcoming American Association of Immunologists (AAI) Annual Meeting - [at noodls] - SOUTH SAN FRANCISCO, Calif., May 5, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will present three scientific posters at the American Association of Immunologists ...
05/05/16 06:18 AMEARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q1 Earnings Report - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): -Earnings: -$17.46 million in Q1 vs. -$18.19 million in the same period last year. -EPS: -$0.19 in Q1 vs. -$0.21 in the same period last year. -Analysts projected -$0.19 per share ...
05/05/16 06:18 AMRigel Pharmaceuticals Inc.: Rigel Announces First Quarter 2016 Financial Results - SOUTH SAN FRANCISCO, Calif., May 3, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2016. 'We look forward to our upcoming Phase 3 data as we continue with our planning ...
05/04/16 09:25 AMEdited Transcript of RIGL earnings conference call or presentation 3-May-16 9:00pm GMT -
05/03/16 04:32 PMRIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -
05/03/16 04:00 PMRigel Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today -
05/03/16 03:42 PMRigel Pharmaceuticals EPS in-line, beats on revenue -
05/03/16 03:30 PMRigel Announces First Quarter 2016 Financial Results - [at noodls] - SOUTH SAN FRANCISCO, Calif., May 3, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2016. ... This is an abstract of ...
05/03/16 03:28 PMRIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report -
05/03/16 03:17 PM4:17 pm Rigel Pharma beats by $0.02, beats on revs -
05/03/16 06:07 AMQ1 2016 Rigel Pharmaceuticals Inc Earnings Release - After Market Close -
05/03/16 06:03 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) 50-day MA At $2.390 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) 50-day MA At $2.390Investor NewswireAs per the technical analysis, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock is trading $0.435 away +18.215% from 50-day MA of $2.390, and $0.090 or +3.296% away 200-day MA of $2.735. Discounting today's price, the stock's price is $-1.985 off ...Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Broker Price Targets For The Coming WeekShare Trading NewsRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Short Interest Decreased By 4.53%B.O.D.Y ConfidentialActive Stocks: Uni-Pixel, Inc. (NASDAQ:UNXL), Oracle Corporation (NYSE:ORCL), Rigel Pharmaceuticals, Inc ...Benchmark Monitorall 5 news articles »
04/29/16 06:40 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for April 27 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for April 27Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on Apr. 27, as the stock lost 0.34% to a closing price of $2.92. The stock saw 720,667 shares trade hands over the course of the day on 2,152 trades. Given that the stock's average ...
04/27/16 07:12 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for April 25 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for April 25Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on Apr. 25, as the stock gained 2.86% to a closing price of $2.88. The stock saw 740,744 shares trade hands over the course of the day on 2,405 trades. Given that the stock's average ...and more »
04/26/16 06:30 AMRigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results - [PR Newswire] - SOUTH SAN FRANCISCO, Calif., April 26, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2016 financial results after market close on ...
04/25/16 06:41 AMStock Earnings Overview: Rigel Pharmaceuticals (NASDAQ:RIGL) - News Oracle - Stock Earnings Overview: Rigel Pharmaceuticals (NASDAQ:RIGL)News OracleLast Trade: The Company rose 12.45% and finished at $2.80. The daily volume was measured at 1.45 million shares. The 52-week high of the share price is $5.20 and the 52-week low is $1.88. The company has a market cap of $287.43 million. Its latest ...
04/25/16 06:41 AMAnalyst's Ratings Review: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - The Point Review - The Point ReviewAnalyst's Ratings Review: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)The Point ReviewRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) received “Upgrade” rating by JP Morgan in a research note issued to investors on Apr-22-16 from Neutral to Overweight. Analysts presently have a $5.00 price target on the company's stock, however according to ...
04/24/16 06:15 AMTraders Are Bullish Rigel Pharmaceuticals, Inc. After Today's Gap Up - The Post - Traders Are Bullish Rigel Pharmaceuticals, Inc. After Today's Gap UpThe PostThe stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) gapped up by $0.12 today and has $6.89 target or 146.00% above today's $2.80 share price. The 6 months technical chart setup indicates low risk for the $287.43 million company. The gap was ...
04/24/16 06:15 AMRigel Pharma Gets Bulls From JPMorgan Before New Phase 3 Data: What To Know - Benzinga - Web Breaking NewsRigel Pharma Gets Bulls From JPMorgan Before New Phase 3 Data: What To KnowBenzingaJPMorgan's Anupam Rama believes data from the two phase 3 trials of fostamatinib would be positive and that Rigel Pharmaceuticals, Inc. RIGL 12.04%'s stock could see 90-150 percent upside if that was the case. The analyst upgraded the rating on the ...Rigel Pharmaceuticals Inc. (RIGL) Jumps 12.45% on April 22Equities.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Book Value Stands At $1.09Vanguard TribuneNew Analyst Ratings On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Risers & FallersWeb Breaking News -Sonoran Weekly Review -CCH Daily Newsall 8 news articles »
04/23/16 06:29 AMRigel Pharmaceuticals Inc. (RIGL) Jumps 12.45% on April 22 - Equities.com - Web Breaking NewsRigel Pharmaceuticals Inc. (RIGL) Jumps 12.45% on April 22Equities.comRigel Pharmaceuticals Inc. (RIGL) was among the biggest gainers on the Russell 2000 for Friday April 22 as the stock popped 12.45% to $2.80, representing a gain of $0.31 per share. Some 1.44 million shares traded hands on 6,160 trades, compared with an ...Rigel Pharma Gets Bulls From JPMorgan Before New Phase 3 Data: What To KnowBenzingaRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Book Value Stands At $1.09Vanguard TribuneNew Analyst Ratings On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Risers & FallersWeb Breaking News -Sonoran Weekly Review -CCH Daily Newsall 8 news articles »
04/22/16 05:21 AMRigel Pharma upgraded by JP Morgan -
04/20/16 07:32 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Is Trading $-0.2230 Away Its 200-day MA Of $2.7331 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Is Trading $-0.2230 Away Its 200-day MA Of $2.7331Investor NewswireThe technical analysis of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock confirms it is trading $0.2141 away +9.3249% from its fifty-day moving average of $2.2960, and it is trading $-0.2230 or -8.1589% away 200-day MA of $2.7331. After the last close ...
04/15/16 10:07 AMRigel Pharmaceuticals Inc. (RIGL) Jumps 5.74% on April 13 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) Jumps 5.74% on April 13Equities.comRigel Pharmaceuticals Inc. (RIGL) was among the biggest gainers on the Russell 2000 for Wednesday April 13 as the stock popped 5.74% to $2.58, representing a gain of $0.14 per share. Some 282,487 shares traded hands on 1,413 trades, compared with ...
04/14/16 11:28 AMRigel Pharma (RIGL) to Present Three Scientific Posters at AACR - StreetInsider.com - Rigel Pharma (RIGL) to Present Three Scientific Posters at AACRStreetInsider.comRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will present three scientific posters at the American Association of Cancer Research meeting in New Orleans, Louisiana from April 16 - 20, 2016. The posters will provide data from the ...
04/13/16 12:17 PMCan Shares Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hit $10? - Stocks Daily - Can Shares Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hit $10?Stocks DailyZacks rating approach measures the research firms' estimates on an easy scale of one to five. A score towards 1-2 band indicates a Buy recommendation; three implies a 'Hold rating and, 4 to 5 score signifies Sell consensus. Following the poll, the ...and more »
04/13/16 12:17 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analyst Review - Risers & Fallers - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). According to the latest broker reports outstanding on Tuesday 12th of April, 1 analyst has a rating of “strong buy”, 0 ...Is Rigel Pharmaceuticals, Inc.'s Fuel Running Low? The Stock Just Declined AgainFranklin Independentall 2 news articles »
04/12/16 06:45 AMRigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference - [at noodls] - SOUTH SAN FRANCISCO, Calif., April 12, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will present three scientific posters at the American Association of Cancer ...
04/11/16 01:07 PMBroker Outlook For The Week Ahead Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Share Trading News - Broker Outlook For The Week Ahead Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Share Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). The most recent broker reports which have been released note that 1 ...
04/08/16 10:04 AMBroadfin Capital Lowers stake in Rigel Pharmaceuticals (RIGL) - Street Edition - Broadfin Capital Lowers stake in Rigel Pharmaceuticals (RIGL)Street EditionRigel Pharmaceuticals (RIGL) : Broadfin Capital reduced its stake in Rigel Pharmaceuticals by 39.02% during the Q4 period. The investment management company now holds a total of 3,125,282 shares of Rigel Pharmaceuticals which is valued at $6.4 ...
About Rigel Pharmaceuticals

Rigel Pharmaceuticals logoRigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. It has various product candidates in development: fostamatinib; R348; two oncology product candidates, and two preclinical programs. Fostamatinib is an oral spleen tyrosine kinase (SYK) inhibitor. R348 is a topical janus kinase (JAK)/SYK inhibitor. It is conducting research in the disease areas of inflammation/immunology and muscle wasting/muscle endurance.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RIGL
  • CUSIP: 76655960
Key Metrics:
  • Previous Close: $2.31
  • 50 Day Moving Average: $2.44
  • 200 Day Moving Average: $2.58
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $212.85M
  • Current Quarter EPS Consensus Estimate: $-0.58 EPS
Additional Links:
Rigel Pharmaceuticals (NASDAQ:RIGL) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha